MIT introduces AI based breast cancer diagnostic model

Date: 2017-10-19   Author: Saipriya Iyer  Category: #industry

MIT introduces AI based breast cancer diagnostic model

This Thursday, the breast cancer therapeutics industry space witnessed one of the biggest scoops of recent times, with MIT unveiling an AI based model that would be able to detect breast cancer much more efficiently and accurately.  Reportedly, scholars of Massachusetts Institute of Technology’s CSAIL (Computer Science and Artificial Intelligence Laboratory) in conjunction with Massachusetts General Hospital in Boston have incorporated machine learning in the design of the new model. Experts claim integration of AI technology enables the platform to accurately detect high risk lesions, without undergoing any kind of invasive treatments.

Allegedly, the so dubbed ‘random-forest classifier’ model, as of now, is integrated with information related to 600 existing cases. The claimed classifier would use these information for the identification of different patterns sourced from various data points, ranging from medical history to demographics. If experts are to be believed, through this new model, doctors would be able to diagnose more accurately whether the lesions are carcinomatous, prior to undergoing any kind of biopsy.

Presently, breast cancer therapeutics space seems to be in experimental stages. While some doctors perform surgical operations in all the cases of high-risk lesions, others look for specific lesions that have a higher probability of becoming cancerous before operation. As per reliable sources, MIT’s new model could accurately diagnose almost 97% of breast cancers, in contrast to surgical approaches on high-risk lesions which has a record of curing 79% of the cases.

Though traditional mammography is generally performed to identify lesions, this testing technology fails to authentically detect high risk lesions with full proof accuracy, cite experts. In fact, 90% of these lesions turn out to be benign after expensive invasive treatments are performed. MIT’s state of the art diagnostic approach might bring a shift in breast cancer therapy model, carving a transition to a more outcome based medical diagnosis, cite experts.



About Author


Saipriya Iyer linkdin-boxtwitter

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

Post Recommendents

Innovations in surveillance system—a growth enabler in air traffic management

Author: Saipriya Iyer

Transforming air traffic management into a more interoperable, automated, modular and scalable system will potentially reap rewards from developments in virtualization and digital technologies. Seamless high-performing...


Stents industry to witness robust technological innovations with ongoing R&D activities

Author: Pankaj Singh

One of the fastest emerging verticals within the healthcare and medical devices space, the global stents market is set to witness numerous interesting trends in the coming years. Ongoing research and development in the...


Amazon India launches ‘Select’ program to assist emerging brands

Author: Shikha Sinha

E-commerce giant Amazon has reportedly started a new program called ‘Select’ in India. As per trusted sources, the program will enable emerging brands in the country to get access to a suite of brand buildi...